Research programme: antiphospholipid syndrome therapy - PolyTherics/University College London
Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator PolyTherics; University College London
- Class Proteins
- Mechanism of Action Antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Antiphospholipid syndrome
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Antiphospholipid-syndrome in United Kingdom (Parenteral)
- 27 Sep 2010 Early research in Antiphospholipid syndrome in United Kingdom (Parenteral)